Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 21 02 2023
accepted: 15 07 2023
medline: 11 9 2023
pubmed: 8 9 2023
entrez: 8 9 2023
Statut: epublish

Résumé

Chagas disease, a neglected tropical disease, is now considered a worldwide health concern as a result of migratory movements from Central and South America to other regions that were considered free of the disease, and where the epidemiological risk is limited to transplacental transmission or blood or organ donations from infected persons. Parasite detection in chronically ill patients is restricted to serological tests that only determine infection by previous infection and not the presence of the parasite, especially in patients undergoing treatment evaluation or in newborns. We have evaluated the use of nucleic acids from both circulating exovesicles and cell-free DNA (cfDNA) from 50 samples twice randomly selected from a total of 448 serum samples from immunologically diagnosed patients in whom the presence of the parasite was confirmed by nested PCR on amplicons resulting from amplification with kinetoplastid DNA-specific primers 121F-122R. Six samples were randomly selected to quantify the limit of detection by qPCR in serum exovesicles. When the nucleic acids thus purified were assayed as a template and amplified with kinetoplastid DNA and nuclear satellite DNA primers, a 100% positivity rate was obtained for all positive samples assayed with kDNA-specific primers and 96% when SAT primers were used. However, isolation of cfDNA for Trypanosoma cruzi and amplification with SAT also showed 100% positivity. The results demonstrate that serum exovesicles contain DNA of mitochondrial and nuclear origin, which can be considered a mixed population of exovesicles of parasitic origin. The results obtained with serum samples prove that both cfDNA and Exovesicle DNA can be used to confirm parasitaemia in chronically ill patients or in samples where it is necessary to demonstrate the active presence of the parasite. The results confirm for the first time the existence of exovesicles of mitochondrial origin of the parasite in the serum of those affected by Chagas disease.

Identifiants

pubmed: 37682970
doi: 10.1371/journal.pone.0282814
pii: PONE-D-23-05006
pmc: PMC10490946
doi:

Substances chimiques

Cell-Free Nucleic Acids 0
DNA 9007-49-2
Nucleic Acids 0
DNA Primers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0282814

Informations de copyright

Copyright: © 2023 Lozano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Mol Diagn. 2015 Sep;17(5):605-15
pubmed: 26320872
J Mol Diagn. 2021 Apr;23(4):389-398
pubmed: 33387697
STAR Protoc. 2023 Apr 21;4(2):102248
pubmed: 37087735
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:115-21
pubmed: 19753466
Sci Adv. 2021 Feb 12;7(7):
pubmed: 33579698
PLoS Negl Trop Dis. 2014 Oct 30;8(10):e3245
pubmed: 25357193
Diagn Microbiol Infect Dis. 2009 Sep;65(1):58-61
pubmed: 19679236
Curr Opin Infect Dis. 2014 Oct;27(5):418-24
pubmed: 25023742
Am J Trop Med Hyg. 1994 Dec;51(6):771-7
pubmed: 7810810
Clin Microbiol Infect. 2020 Jul;26(7):942.e1-942.e5
pubmed: 31760116
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:31-40
pubmed: 19753455
Clin Vaccine Immunol. 2011 Nov;18(11):1850-5
pubmed: 21880857
Front Microbiol. 2018 Jun 01;9:1190
pubmed: 29910793
PLoS Negl Trop Dis. 2012;6(11):e1881
pubmed: 23145201
Am J Trop Med Hyg. 2010 Jan;82(1):55-9
pubmed: 20064996
Int J Mol Sci. 2021 May 13;22(10):
pubmed: 34068436
Acta Trop. 2018 Aug;184:38-52
pubmed: 28941731
Lancet Infect Dis. 2001 Sep;1(2):92-100
pubmed: 11871482
Pathogens. 2022 Oct 25;11(11):
pubmed: 36364982
Mem Inst Oswaldo Cruz. 2003 Jul;98(5):577-91
pubmed: 12973523
Methods. 2012 Feb;56(2):293-304
pubmed: 22285593
Bioeng Transl Med. 2017 Mar;2(1):70-80
pubmed: 28529978
Sci Rep. 2023 May 10;13(1):7618
pubmed: 37165081
PLoS Negl Trop Dis. 2011 Apr 26;5(4):e1136
pubmed: 21572510
PLoS One. 2020 Nov 12;15(11):e0241921
pubmed: 33180799
Am J Trop Med Hyg. 2022 Nov 14;107(5):992-995
pubmed: 36395748
Acta Trop. 2007 Sep;103(3):195-200
pubmed: 17662227
Int J Mol Sci. 2019 Nov 14;20(22):
pubmed: 31739393
Acta Trop. 2022 Jan;225:106222
pubmed: 34757045
PLoS One. 2019 Apr 18;14(4):e0215623
pubmed: 30998741
Trends Parasitol. 2016 May;32(5):378-391
pubmed: 26847654
PLoS Negl Trop Dis. 2009;3(4):e419
pubmed: 19381287
Epidemiol Serv Saude. 2016 Jun;25(spe):7-86
pubmed: 27869914
Ann Trop Med Parasitol. 2007 Dec;101(8):673-9
pubmed: 18028728
Oncogenesis. 2022 Sep 15;11(1):54
pubmed: 36109501
Front Cell Infect Microbiol. 2021 Jul 29;11:694470
pubmed: 34395309
Int J Mol Sci. 2023 May 03;24(9):
pubmed: 37175888
Eur J Pharm Sci. 2017 Jan 1;96:93-98
pubmed: 27640113
Pathogens. 2021 Jun 09;10(6):
pubmed: 34207764
Am J Trop Med Hyg. 2006 Dec;75(6):1078-81
pubmed: 17172369
Front Genet. 2013 Jul 30;4:142
pubmed: 23908664
Rev Chilena Infectol. 2008 Oct;25(5):380-3
pubmed: 18949152
Clin Microbiol Rev. 2022 Apr 20;35(2):e0015221
pubmed: 35239422
PLoS One. 2019 Aug 21;14(8):e0221100
pubmed: 31433828
Am J Transplant. 2007 Jun;7(6):1633-40
pubmed: 17511688
Trop Med Int Health. 2023 Jan;28(1):2-16
pubmed: 36420767
JAMA. 2007 Nov 14;298(18):2171-81
pubmed: 18000201
Methods Mol Biol. 2021;2369:301-317
pubmed: 34313995
PLoS Negl Trop Dis. 2013;7(1):e2000
pubmed: 23350002
Biochim Biophys Acta. 2012 Jul;1820(7):940-8
pubmed: 22503788
Expert Rev Anti Infect Ther. 2015 Aug;13(8):995-1029
pubmed: 26162928
Diagn Microbiol Infect Dis. 2002 May;43(1):39-43
pubmed: 12052627
J Proteome Res. 2013 Feb 1;12(2):883-97
pubmed: 23214914
Sci Rep. 2016 Sep 19;6:33641
pubmed: 27640641
Transplantation. 2018 Feb;102(2S Suppl 2):S1-S7
pubmed: 29381572
Infect Dis Clin North Am. 1993 Sep;7(3):487-502
pubmed: 8254156
Sci Rep. 2017 Mar 15;7:44451
pubmed: 28294160
Ann Trop Med Parasitol. 1999 Oct;93(7):689-94
pubmed: 10715696
Parasit Vectors. 2015 Mar 12;8:154
pubmed: 25890282
J Immunol Methods. 2014 May;407:120-6
pubmed: 24735771
J Clin Microbiol. 2021 Nov 18;59(12):e0106221
pubmed: 34469183
Pharmacol Rev. 2012 Jul;64(3):676-705
pubmed: 22722893
Trials. 2020 Apr 15;21(1):328
pubmed: 32293523
Proteomics Clin Appl. 2015 Apr;9(3-4):358-67
pubmed: 25684126
Front Microbiol. 2019 Aug 14;10:1854
pubmed: 31474955
Pathog Glob Health. 2016 Sep;110(6):228-232
pubmed: 27666187
Trans R Soc Trop Med Hyg. 1996 Mar-Apr;90(2):129-32
pubmed: 8761570
PLoS Negl Trop Dis. 2023 Apr 14;17(4):e0011290
pubmed: 37058542
J Heart Lung Transplant. 2004 Dec;23(12):1345-8
pubmed: 15607662
J Clin Microbiol. 1992 Nov;30(11):2864-8
pubmed: 1452655
Parasitology. 2018 Dec;145(14):1837-1843
pubmed: 29661257
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Transpl Infect Dis. 2017 Dec;19(6):
pubmed: 28941300
PLoS Negl Trop Dis. 2019 Feb 21;13(2):e0007163
pubmed: 30789912
Mem Inst Oswaldo Cruz. 2007 Oct 30;102 Suppl 1:113-22
pubmed: 17992371
BMC Infect Dis. 2010 Nov 25;10:337
pubmed: 21108793
J Parasitol. 2005 Dec;91(6):1468-73
pubmed: 16539033
Sci Rep. 2020 Dec 7;10(1):21346
pubmed: 33288809
Arch Gynecol Obstet. 2012 Apr;285(4):919-23
pubmed: 21927962
Mem Inst Oswaldo Cruz. 1996 Jan-Feb;91(1):87-93
pubmed: 8734955
Biochim Biophys Acta. 1979 Jan 19;550(2):222-32
pubmed: 365244
PLoS One. 2013 May 27;8(5):e64450
pubmed: 23724050
Mol Biochem Parasitol. 1988 Jan 1;27(1):63-70
pubmed: 2830509
Trop Med Int Health. 2000 Apr;5(4):293-301
pubmed: 10810029
J Clin Microbiol. 1983 Aug;18(2):327-30
pubmed: 6413530
Biomed Res Int. 2018 Jan 30;2018:8545347
pubmed: 29662902
J Cancer. 2021 Jun 16;12(16):5035-5045
pubmed: 34234872

Auteurs

Noelia Lozano (N)

Area of Parasitology, Department of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Valencia, Spain.
Servicio de Microbiología y Parasitología Clínica, Hospital Universitario y Politécnico La Fe-IIS La Fe, Valencia, Spain.

Mercedes Gomez Samblas (MG)

Grupo de Bioquímica y Parasitología Molecular (CTS 183), Departamento de Parasitología, Campus de Fuentenueva, Instituto de Biotecnología, Universidad de Granada, Granada, Spain.

Eva Calabuig (E)

Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario y Politécnico La Fe-IIS La Fe, Valencia, Spain.

María José Giménez Martí (MJ)

Servicio de Microbiología y Parasitología Clínica, Hospital Universitario y Politécnico La Fe-IIS La Fe, Valencia, Spain.

Maria Dolores Gómez Ruiz (MD)

Servicio de Microbiología y Parasitología Clínica, Hospital Universitario y Politécnico La Fe-IIS La Fe, Valencia, Spain.

José Miguel Sahuquillo Arce (JMS)

Servicio de Microbiología y Parasitología Clínica, Hospital Universitario y Politécnico La Fe-IIS La Fe, Valencia, Spain.

Sergio Sequera-Arquelladas (S)

Unidad de Enfermedades Infecciosas, Hospital Universitario Virgen de las Nieves, Granada, Spain.

José Miguel Molina Moreno (JMM)

Servicio de Microbiología y Parasitología Clínica, Hospital Universitario y Politécnico La Fe-IIS La Fe, Valencia, Spain.

M Trelis (M)

Area of Parasitology, Department of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Valencia, Spain.
Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, University of Valencia-Health Research Institute La Fe, Valencia, Spain.

Antonio Osuna (A)

Grupo de Bioquímica y Parasitología Molecular (CTS 183), Departamento de Parasitología, Campus de Fuentenueva, Instituto de Biotecnología, Universidad de Granada, Granada, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH